The observation that all the attempts to characterize imidazoline (I) receptors have been carried out with non-selective or poorly selective ligands prompted us to undertake research aimed at developing selective ligand(s). In previous work using, as a starting point, cirazoline 1, a potent alpha(1)-adrenergic receptor agonist that also binds to I receptors, we showed that removal of the cyclopropyl ring (2) retains high affinity for I-2 receptors while reducing alpha(1)-adrenergic agonist activity. However, it was felt that this residual, albeit modest, alpha(1)-adrenergic agonist activity might diminish the usefulness of compound 2, and we now report on our continuing efforts in this field. Starting from compound 2, we first eliminated the alpha(1)-agonist component by isosteric replacement and then, by means of conformational restrictions on compound 7, succeeded in discovering tracizoline (9) and benazoline (12). These two new ligands with high affinity (pK(i) value 8.74 and 9.07, respectively) and unprecedented selectivity with respect to both alpha(2)-(I-2/alpha(2) 7,762 and 18,621) and alpha(1)-(I-2/alpha(1) 2,344 and 2,691) adrenergic receptors, are valuable tools in the study of I receptor structure and function. In addition, the large number of derivatives studied has allowed us to establish congruent qualitative structure-activity relationships and identify some structural elements governing affinity and selectivity.

Imidazoline receptors: Qualitative structure-activity relationships and discovery of tracizoline and benazoline. Two ligands with high affinity and unprecedented selectivity / M., Pigini; P., Bousquet; A., Carotti; M., Dontenwill; M., Giannella; R., Moriconi; A., Piergentili; W., Quaglia; Sk, Tayebati; Brasili, Livio. - In: BIOORGANIC & MEDICINAL CHEMISTRY. - ISSN 0968-0896. - STAMPA. - 5:(1997), pp. 833-841.

Imidazoline receptors: Qualitative structure-activity relationships and discovery of tracizoline and benazoline. Two ligands with high affinity and unprecedented selectivity

BRASILI, Livio
1997

Abstract

The observation that all the attempts to characterize imidazoline (I) receptors have been carried out with non-selective or poorly selective ligands prompted us to undertake research aimed at developing selective ligand(s). In previous work using, as a starting point, cirazoline 1, a potent alpha(1)-adrenergic receptor agonist that also binds to I receptors, we showed that removal of the cyclopropyl ring (2) retains high affinity for I-2 receptors while reducing alpha(1)-adrenergic agonist activity. However, it was felt that this residual, albeit modest, alpha(1)-adrenergic agonist activity might diminish the usefulness of compound 2, and we now report on our continuing efforts in this field. Starting from compound 2, we first eliminated the alpha(1)-agonist component by isosteric replacement and then, by means of conformational restrictions on compound 7, succeeded in discovering tracizoline (9) and benazoline (12). These two new ligands with high affinity (pK(i) value 8.74 and 9.07, respectively) and unprecedented selectivity with respect to both alpha(2)-(I-2/alpha(2) 7,762 and 18,621) and alpha(1)-(I-2/alpha(1) 2,344 and 2,691) adrenergic receptors, are valuable tools in the study of I receptor structure and function. In addition, the large number of derivatives studied has allowed us to establish congruent qualitative structure-activity relationships and identify some structural elements governing affinity and selectivity.
5
833
841
Imidazoline receptors: Qualitative structure-activity relationships and discovery of tracizoline and benazoline. Two ligands with high affinity and unprecedented selectivity / M., Pigini; P., Bousquet; A., Carotti; M., Dontenwill; M., Giannella; R., Moriconi; A., Piergentili; W., Quaglia; Sk, Tayebati; Brasili, Livio. - In: BIOORGANIC & MEDICINAL CHEMISTRY. - ISSN 0968-0896. - STAMPA. - 5:(1997), pp. 833-841.
M., Pigini; P., Bousquet; A., Carotti; M., Dontenwill; M., Giannella; R., Moriconi; A., Piergentili; W., Quaglia; Sk, Tayebati; Brasili, Livio
File in questo prodotto:
Non ci sono file associati a questo prodotto.
Pubblicazioni consigliate

Caricamento pubblicazioni consigliate

Licenza Creative Commons
I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris

Utilizza questo identificativo per citare o creare un link a questo documento: http://hdl.handle.net/11380/306603
Citazioni
  • ???jsp.display-item.citation.pmc??? 7
  • Scopus 59
  • ???jsp.display-item.citation.isi??? 55
social impact